Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG: 6990)
Hong Kong
· Delayed Price · Currency is HKD 168.00
-0.80 (-0.47%)
Dec 31, 2024, 4:00 PM HKT
Sichuan Kelun-Biotech Biopharmaceutical Market Cap
Sichuan Kelun-Biotech Biopharmaceutical has a market cap or net worth of 37.33 billion as of January 2, 2025. Its market cap has increased by 77.75% in one year.
Market Cap
37.33B
Enterprise Value
34.27B
Revenue
2.02B
Ranking
n/a
PE Ratio
n/a
Stock Price
168.00
Market Cap Chart
Since July 11, 2023, Sichuan Kelun-Biotech Biopharmaceutical's market cap has increased from 13.49B to 37.33B, an increase of 176.71%. That is a compound annual growth rate of 98.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 2, 2025 | 37.33B | 2.57% |
| Dec 31, 2024 | 36.39B | 61.34% |
| Dec 29, 2023 | 22.56B | 67.21% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 152.75B |
| Hansoh Pharmaceutical Group Company | 98.98B |
| JD Health International | 84.44B |
| WuXi Biologics | 68.21B |
| Sinopharm Group | 65.07B |
| Innovent Biologics | 58.15B |
| Sino Biopharmaceutical | 56.25B |
| CSPC Pharmaceutical Group | 53.70B |